Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. (Q53353482)

13 May 2018

title

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. (English)

1 reference

13 May 2018

0 references

0 references

1 reference

acute myeloid leukemia

1 reference

Siegler U

1

1 reference

13 May 2018

Kalberer CP

2

1 reference

13 May 2018

Nowbakht P

3

1 reference

13 May 2018

Sendelov S

4

1 reference

13 May 2018

Meyer-Monard S

5

1 reference

13 May 2018

Wodnar-Filipowicz A

6

1 reference

13 May 2018

publication date

1 December 2005

1 reference

13 May 2018

published in

Leukemia

1 reference

13 May 2018

volume

19

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

page(s)

2215-2222

1 reference

13 May 2018

The biology of human natural killer-cell subsets

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Natural killer cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

New aspects of natural-killer-cell surveillance and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Cellular immunotherapy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Large-scale generation of natural killer lymphocytes for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

The role of autologous natural killer cells in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Identification of natural killer cell receptor phenotypes associated with leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Interleukin-2 and interleukin-15: immunotherapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403985

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403985

1 reference

13 May 2018

1 reference

13 May 2018